Sarepta Therapeutics exceeded 2024 net product revenue guidance and reaffirmed its 2025 outlook, partly due to strong growth for Duchenne muscular dystrophy drug Elevidys.

How to watch Baltimore Ravens vs Buffalo Bills NFL playoff game on Sunday, Jan. 19, 2025, with time, TV channel, streaming, ...

Shares of iRhythm Technologies declined after the company shared its preliminary revenue for 2024 and financial outlook for 2025. IRhythm stock fell 8%, to $90.35, midday Monday. It is down 8% over ...